PARMAX PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Parmax Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-8.35₹ -3.03
As on Jan 16, 2026, 4:01 PM IST
Parmax Pharma Price Performance
Today's LowToday's High
₹32.05₹37.85
₹33.27
52 Weeks' Low52 Weeks' High
₹28.00₹55.02
₹33.27
Open Price
₹32.05
Prev. Close
₹36.30
Volume
1,017
Over the last 5 years, the share price of Parmax Pharma has gained 5.88% CAGR. Over the past year, the corresponding return has been -19.40%.
Parmax Pharma’s current P/E of -2.63x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Parmax Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Parmax Pharma | -10.06 | -1.10 | -3.57 | -20.75 | -19.40 | -3.04 | 5.88 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Parmax Pharma has declined 19.40% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Parmax Pharma has underperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
Parmax Pharma Financials
Parmax Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 37.38 | 36.39 |
| 10 | 35.24 | 35.56 |
| 20 | 33.76 | 34.53 |
| 50 | 33.18 | 33.73 |
| 100 | 33.42 | 34.36 |
| 200 | 37.48 | 36.07 |
Parmax Pharma Share Holding Pattern
In the latest quarter, Parmax Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 69.21% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Parmax Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 12, 2026, 11:37 PM IST | Parmax Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Nov 18, 2025, 2:51 AM IST | Parmax Pharma - Results-Delay in Financial Results |
| Nov 18, 2025, 2:47 AM IST | Parmax Pharma - Board Meeting Outcome for The Board Meeting Was Initially Rescheduled On November 15, 2025 And Thenafter On T |
| Nov 15, 2025, 3:21 PM IST | Parmax Pharma - Board Meeting Intimation for Reschedule Of Board Meeting Supposed To Be Held On November 14, 2025 |
| Nov 09, 2025, 3:28 AM IST | Parmax Pharma - Board Meeting Intimation for For Approval Of Unaudited Financial Results For Quarter Ended September 30, 2025 |
About Parmax Pharma
Parmax Pharma Ltd. is a Public Limited Listed company incorporated on 02/11/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1994PLC023504 and registration number is 023504. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 28.20 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 20, Survey No. 52, Rajkot Gujarat 360311
- Contact
Management
- Dr. Umang Alkesh GosaliaManaging Director
- Ms. Ami R ShahIndependent Director
- Mr. Nikhil S UchatIndependent Director
FAQs on Parmax Pharma Share Price
What is the share price of Parmax Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Parmax Pharma is ₹33.27 as on Jan 16, 2026.
What kind of stock is Parmax Pharma?
The Parmax Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Parmax Pharma?
The market cap of Parmax Pharma is ₹12.45 Cr as on Jan 16, 2026.
What are today's High and Low prices of Parmax Pharma?
Today’s highest and lowest price of Parmax Pharma are ₹37.85 and ₹32.05.
What are the 52 Week High and 52 Week Low of Parmax Pharma?
The 52-week high/low is the highest and lowest price at which Parmax Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Parmax Pharma is ₹55.02 and 52-week low of Parmax Pharma is ₹28.00 as on Jan 16, 2026.
How has the Parmax Pharma performed historically in terms of returns?
The Parmax Pharma has shown returns of -8.35% over the past day, -1.1% for the past month, -3.57% over 3 months, -19.4% over 1 year, -3.04% across 3 years, and 5.88% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Parmax Pharma?
P/E ratio of and PB ratio of Parmax Pharma are -2.63 and -2.25 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse